The AHA and other plaintiffs late Friday asked a federal district judge to set a firm June deadline for the Department of Health and Human Services to propose remedies to the nearly 30 percent cuts to Medicare payments affecting certain hospitals that participate in the 340B Drug Pricing Program. The judge last week had set an Aug. 5 deadline for the remedies.
 
In the filing, the plaintiffs said “it is important that the Court require HHS to propose its remedy by the end of June 2019 or shortly thereafter, since unless there is a Court order on the remedy in this case this summer, Defendants may issue a 2020 OPPS [outpatient prospective payment system] rule reducing reimbursements for 340B drugs by nearly 30 percent in violation of law, just as they did in 2018 and 2019.” While the final OPPS rule generally is issued by the Centers for Medicare & Medicaid Services in November, the agency typically issues its proposal in late July. 
 
A federal district court judge last week said HHS would get "first crack at crafting appropriate remedial measures" to the cuts, and also held that, like the 2018 cuts, the 2019 cuts to 340B hospitals were unlawful.
 

Related News Articles

Headline
A U.S. district court judge for the District of Columbia May 15 ruled the Department of Health and Human Services must preapprove the use of 340B “rebate…
Headline
The AHA May 14 filed an amicus brief in the U.S. District Court for the District of South Dakota in defense of the state’s 340B contract pharmacy law…
Headline
The AHA May 9 urged the Department of Health and Human Services to deny drug companies’ requests to approve their unlawful 340B rebate models. “The 340B…
Headline
The AHA May 8 filed an amicus brief in the U.S. District Court for the District of Nebraska in defense of the state’s 340B contract pharmacy law prohibiting…
Headline
During its 2025 Annual Membership Meeting May 5 in Washington, D.C., the AHA honored several health care leaders including:Award for Excellence to Patricia…
Headline
The AHA May 1 expressed concerns to the Centers for Medicare & Medicaid Services about the payment process established under the Medicare Drug…